Drug researchers
leak secrets to Wall St.


Despite confidentiality contracts, doctors are divulging details of their ongoing drug research — for a fee — to elite investors.

Experts say the practice breaks insider-trading laws, violates medical ethics and jeopardizes vital research. And government regulators seem to know nothing about it.  Read story

Updates: The SEC investigation and other follow-up stories

The practice is a moral cesspool.

Arthur Caplan, director of the Center for Bioethics, University of Pennsylvania

Moving the marketMoving
the market
3 cases where an inside report sparked stock movement

How it worksHow it works
How Wall Street
gets the inside scoop on drug testing
Dr. Robert FiglinInside a conference call
Investors quiz a cancer-research doctor: a recorded conversation